Direkt zum Inhalt

Houot, Roch ; Poeschel, Viola ; Altmann, Bettina ; Angel, Stephanie ; Thurner, Lorenz ; Illmer, Thomas ; Andre, Marc ; Dreyling, Martin ; Maisonneuve, Hervé ; Tilly, Hervé ; Mayer, Stephanie ; Casasnovas, Olivier ; Le Gouill, Steven ; Offner, Fritz ; Cartron, Guillaume ; Kerkhoff, Andrea ; Weber, Thomas ; Hoffmann, Joerg ; Ziepert, Marita ; Klapper, Wolfram ; Itti, Emmanuel ; Hellwig, Dirk ; Natchkebia, Giorgi ; de Leval, Laurence ; Rosenwald, Andreas ; Haioun, Corinne ; Dercle, Laurent ; Gaulard, Philippe ; Held, Gerhard

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

Houot, Roch, Poeschel, Viola, Altmann, Bettina, Angel, Stephanie, Thurner, Lorenz, Illmer, Thomas, Andre, Marc, Dreyling, Martin, Maisonneuve, Hervé, Tilly, Hervé, Mayer, Stephanie, Casasnovas, Olivier , Le Gouill, Steven, Offner, Fritz, Cartron, Guillaume, Kerkhoff, Andrea, Weber, Thomas, Hoffmann, Joerg, Ziepert, Marita, Klapper, Wolfram, Itti, Emmanuel, Hellwig, Dirk , Natchkebia, Giorgi, de Leval, Laurence, Rosenwald, Andreas, Haioun, Corinne, Dercle, Laurent, Gaulard, Philippe and Held, Gerhard (2022) Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. HemaSphere 6 (2), e672.

Date of publication of this fulltext: 29 Feb 2024 12:58
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleHemaSphere
Publisher:Lippincott
Place of Publication:PHILADELPHIA
Volume:6
Number of Issue or Book Chapter:2
Page Range:e672
Date2022
InstitutionsMedicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Abteilung für Nuklearmedizin
Identification Number
ValueType
10.1097/HS9.0000000000000672DOI
KeywordsPD-1
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID57612

Export bibliographical data

Owner only: item control page

nach oben